ROBERTO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 322
EU - Europa 201
AS - Asia 116
AF - Africa 12
OC - Oceania 3
SA - Sud America 2
Totale 656
Nazione #
US - Stati Uniti d'America 319
GB - Regno Unito 87
CN - Cina 53
VN - Vietnam 43
IT - Italia 26
DE - Germania 18
SE - Svezia 18
UA - Ucraina 18
IN - India 16
FR - Francia 12
RU - Federazione Russa 10
ZA - Sudafrica 9
EE - Estonia 4
AU - Australia 3
CA - Canada 3
IR - Iran 3
TG - Togo 3
CH - Svizzera 2
GR - Grecia 2
NL - Olanda 2
BR - Brasile 1
EC - Ecuador 1
IE - Irlanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 656
Città #
Southend 80
Fairfield 64
Ashburn 27
Wilmington 25
Houston 24
Woodbridge 24
Princeton 23
Dong Ket 22
Seattle 20
Chandler 18
Cambridge 13
Jacksonville 13
Bologna 9
Padova 9
Westminster 9
Berlin 8
Jinan 8
Nanjing 8
Nanchang 6
Saint Petersburg 5
Shenyang 5
Ann Arbor 4
Medford 4
San Venanzo 4
Ardabil 3
Changsha 3
Dearborn 3
Haikou 3
Hebei 3
Lomé 3
Monmouth Junction 3
Tianjin 3
Toronto 3
Amsterdam 2
Canberra 2
Falls Church 2
Fuzhou 2
Hangzhou 2
Lanzhou 2
San Diego 2
San Mateo 2
Taiyuan 2
Athens 1
Beijing 1
Biella 1
Birmingham 1
Bratislava 1
Frankfurt am Main 1
Hanover 1
Hefei 1
Jiaxing 1
Kunming 1
Lausanne 1
London 1
Ludwigshafen 1
Norwalk 1
Paris 1
Quito 1
Redwood City 1
Riyadh 1
San Francisco 1
San Jose 1
São Paulo 1
Zhengzhou 1
Totale 499
Nome #
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 135
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). 94
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature 94
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 85
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 84
Pattern of Triptan Use in a Sample of the Italian General Population 55
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 45
Ticlopidine’s safety profile: a case/non case study on the basis of the spontaneous ADR reporting in Italy. 43
Factors Influencing the Disproportional Association Between Triptans and Cerebrovascular Events Within the FDA_AERS Database: Causal Association or Reporting Bias? 38
Totale 673
Categoria #
all - tutte 855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201820 0000 05 00 00150
2018/201962 0907 012 60 95014
2019/2020228 397412 2122 2427 3611421
2020/2021109 30426 03 07 710733
2021/2022180 311245 156 29 654441
2022/202369 2333130 00 00 0000
Totale 673